• OPEN AN ACCOUNT
Indian Indices
Sensex
77,598.01 -56.59
( -0.07%)
Global Indices
Nasdaq
51,626.09 -1,142.23
(-2.16%)
Dow Jones
7,338.46 -111.32
(-1.49%)
Hang Seng
61,006.88 -1,358.04
(-2.18%)
Nikkei 225
10,896.96 25.94
(0.24%)
Forex
USD-INR
95.71 -0.26
(-0.27%)
EUR-INR
108.89 -0.40
(-0.37%)
GBP-INR
127.22 -0.62
(-0.49%)
JPY-INR
0.58 0.00
(-0.38%)

EQUITY - MARKET SCREENER

Cella Space Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
532701
INE266H01014
17.5578562
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
5.56
59
EPS(TTM)
Face Value()
Div & Yield %
5.27
10
0
 

ajanta pharma ltd
Ajanta Pharma consolidated net profit rises 18.40% in the March 2026 quarter
May 05,2026
Net profit of Ajanta Pharma rose 18.40% to Rs 266.70 crore in the quarter ended March 2026 as against Rs 225.26 crore during the previous quarter ended March 2025. Sales rose 21.47% to Rs 1421.64 crore in the quarter ended March 2026 as against Rs 1170.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.73% to Rs 1056.00 crore in the year ended March 2026 as against Rs 920.39 crore during the previous year ended March 2025. Sales rose 17.31% to Rs 5452.86 crore in the year ended March 2026 as against Rs 4648.10 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales1421.641170.41 21 5452.864648.10 17
OPM %23.4525.39 -25.5827.10 -
PBDT392.48309.19 27 1550.791333.27 16
PBT347.11269.41 29 1377.651189.16 16
NP266.70225.26 18 1056.00920.39 15